Polares Medical

Executive Summary

Polares Medical is a Swiss medical device company dedicated to addressing the significant unmet clinical need in structural heart disease, specifically mitral valve regurgitation (MR). Founded in 2016 and headquartered in Zug, Switzerland, with operational offices in Lausanne and Palo Alto, the company is developing a novel, minimally invasive device for the treatment of MR. Mitral regurgitation, a common and serious heart valve disorder, affects millions worldwide and has limited effective treatment options, particularly for patients who are not candidates for open-heart surgery. Polares Medical's innovative therapeutic solution aims to provide a safe, durable, and less invasive alternative, potentially transforming the management of this condition.

Upcoming Catalysts (preview)

• TBDInitiation of Pivotal Clinical Trial60% success
• TBDFDA IDE Submission Approval65% success
• TBDSeries B or C Financing Round70% success